MedTrace Logo

Effectiveness and Safety in Maternal and Neonatal Outcomes in Water Birth.

NCT06429111 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 642

Last updated 2024-05-24

No results posted yet for this study

Summary

Childbirth is a unique and non-transferable experience in the life of a woman, her partner and her family. It is a very intense process that requires accompaniment and, in the vast majority of cases, requires analgesic support in order to overcome this life event in an optimal and atraumatic way.

Among the analgesic methods for pain relief during the labor process, there are pharmacological and non-pharmacological methods. From the evidence we know that the most effective pharmacological method is epidural analgesia (EA), while the most recognized non-pharmacological method is immersion in hot water (bathtub) for dilatation and delivery, called waterbirth(WB) At present there is controversy and doubts about the increase in the number of interventions involving the use of epidural analgesia, but there is also controversy about the safety of the use of water, especially in those processes where the birth ends in water. Given the popularity of these two methods, the aim is to study and compare the maternal and neonatal outcomes derived from the use of both methods in order to provide greater knowledge to women in their decision making.

Conditions

  • Natural Childbirth
  • Water Birth
  • Neonatal Asphyxia
  • Outcome, Adverse Birth
  • Labor Pain
  • Obstetric Pain

Interventions

PROCEDURE

Epidural analgesia

Consists of a central nerve block by injecting a local anesthetic near the nerves that transmit pain, in the lumbar region, for pain relief during labor.

PROCEDURE

Immersion water

Consists of the use of hot water immersion in a birthing tub during labor and/or delivery.

Sponsors & Collaborators

  • Universitat Jaume I

    collaborator OTHER

  • Hospital Universitario de la Plana

    collaborator OTHER

  • Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana

    lead OTHER

Principal Investigators

  • Soledad Carregui Vilar, Midwife · Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana

Eligibility

Min Age
17 Years
Max Age
46 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-06-06
Primary Completion
2023-02-24
Completion
2023-03-24

Countries

  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06429111 on ClinicalTrials.gov